BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Wyeth Pharmaceuticals (Pennsylvania) Release: New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma - Data From Phase 3 Study Presented at American Society of Clinical Oncology

  June 2, 2008

   · 

  9 min read
• Drug Development

  IDM Pharma, Inc. Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE) - Data Presented at the 44th American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  7 min read
• Drug Development

  Ipsen and Spirogen’s SJG-136 Shows Encouraging Results in the Treatment of Refractory Solid Tumours At American Society of Clinical Oncology

  June 2, 2008

   · 

  1 min read
• Business

  PharmaLinkFHI Adds Industry Veteran to Leadership Team

  June 2, 2008

   · 

  1 min read
• Drug Development

  Cougar Biotechnology, Inc. Presents Positive CB7630 (Abiraterone Acetate) Phase I and Phase II Data at American Society of Clinical Oncology 2008 Annual Meeting

  June 2, 2008

   · 

  1 min read
• Drug Development

  Bionovo, Inc. Release: Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles - Results Presented at American Society of Clinical Oncology 44TH Annual Meeting

  June 2, 2008

   · 

  5 min read
• Drug Development

  PsychoGenics Inc. Announces Positive Phase-IIa for Its First-in-Class Partial 5-HT1A – 5-HT1B Receptor Agonist in ADHD

  June 2, 2008

   · 

  1 min read
• BioMidwest

  About 60 Clinical Studies Regarding Schering-Plough Corporation’s Oncology Compounds Will be Presented at American Society of Clinical Oncology

  June 2, 2008

   · 

  2 min read
• Business

  MAP Pharmaceuticals, Inc. Appoints Marco Rosa Vice President of Human Resources

  June 2, 2008

   · 

  2 min read
• Drug Development

  Edwards Lifesciences Corporation Receives Additional Questions From the FDA About the LifeStent Product Line

  June 2, 2008

   · 

  2 min read